By August, it aims to provide 300 million doses and has also seen interest from African and Asian countries including Bangladesh. Somani said the overall efficacy of the AstraZeneca vaccine, locally branded COVISHIELD, was 70.42% based on trials done overseas. Poonawalla said they recommended that the AstraZeneca vaccine be administered eight to 10 weeks apart. Bharat Biotech earlier said they could produce up to 300 million doses a year. SII plans to sell the AstraZeneca vaccine to the Indian government at about 250 rupees ($3.42) per dose and 1,000 rupees on the private market.

Source: bd News24 January 03, 2021 16:18 UTC